Chris Evert on Centre Court at Wimbledon, Sunday, July 3, 2022. (Kirsty WigglesworthAP Images)
August 30, 2022 11:44 AM EDTUpdated 02:12 PM
People
Pharma
Marketing

Il­lu­mi­na taps ten­nis star Chris Evert for its first ge­nomics fo­rum along­side Barack Oba­ma and Bill Gates

Nicole DeFeudis

Editor

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Large phar­ma com­pa­nies spell out rea­sons why tar­iffs will harm US in­vest­ments 

Supreme Court to keep mulling state PBM dis­pute as US urges jus­tices to de­cline case

Mer­ck, Dai­ichi Sankyo scrap FDA ap­pli­ca­tion for HER3 ADC af­ter sur­vival miss

DNA gi­ant Il­lu­mi­na spawned an ecosys­tem of com­peti­tors and cus­tomers

In­tel­lia re­ports case of liv­er tox­i­c­i­ty in AT­TR gene edit­ing study

sponsored

From weeks to days: how Aizon In­tel­li­gent Agents trans­form phar­ma val­i­da­tion

A service from the Financial Times